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Abstract: Low-density lipoprotein cholesterol (LDL-C) is frequently
estimated using the empirical Friedewald equation. We compared the
accuracy of the novel equation named as the 180-cell method (180-c),
which estimates LDL-C using a stratification approach, to those of 9
previously suggested formulas, including the Friedewald equation.
We compared the accuracy of 10 equations by calculating intraclass
correlation coefficient (ICC) and weighted kappa index in relation to
direct LDL-C measurement values. Two independent populations used
in the validation were the Severance Hospital LDL-C (SHL) registry
(n¼ 164,358) and the Korea National Health and Nutrition Examination
Survey (KNHANES) 2009 to 2010 (n¼ 3,854), each representing the
hospital patient population and the general Korean population, respect-
ively.
The 180-c and DeLong equations showed the highest ICCs, indi-
cating the best agreement with direct LDL-C measurement. The 180-c
and Chen equations showed the highest kappa indices. For the hyper-
triglyceridemic subpopulation from SHL, the 180-c equation showed
the best agreement with direct LDL-C measurement in terms of ICC.
We compared the novel 180-c method for LDL-C estimation with 9
previous formulas in a non-US population as the first external vali-
dation. The 180-c equation, with Chen equation, appeared to be moreok Kang, MD, PhD ee, MD, PhD,
, MD, and Bong-Soo Cha, MD, PhD
(Medicine 95(14):e3230)
Abbreviations: 180-c = 180-cell method, CVD = cardiovascular
disease, EU = European, HDL-C = high-density lipoprotein
cholesterol, ICC = intraclass correlation coefficient, KNHANES
= Korea National Health and Nutrition Examination Survey, LDL-
C = low-density lipoprotein cholesterol, NCEP = National
Cholesterol Education Program, SHL = Severance Hospital low-
density lipoprotein cholesterol, TC = total cholesterol, US = United
States, VLDL-C = very low-density lipoprotein cholesterol.
INTRODUCTION
C ardiovascular disease (CVD) is one of the most commoncauses of morbidity and mortality worldwide.1 Elevated
low-density lipoprotein cholesterol (LDL-C) has been recog-
nized as an important risk factor for CVD, with clinical trials
conclusively showing that LDL-C lowering therapy can reduce
the risk of CVD.2,3 For this reason, numerous clinical practice
guidelines have continuously identified LDL-C as the primary
target for CVD prevention and therapy.4–7 Understandably,
accurate measurement of LDL-C is essential to proper utiliz-
ation of clinical practice guidelines for patient care. Among
various principles of LDL-C measurement, the ultracentrifugal
method, which is also called as b-quantification, remains as the
reference procedure because LDL-C is unaffected by the pre-
sence of chylomicrons or other triglyceride-rich lipoproteins in
this method. Nevertheless, b-quantification is inadequate for
routine clinical laboratory use as it is labor-intensive, time-
consuming and required impractically large volume of plasma.
Therefore, LDL-C is alternatively estimated using the empirical
Friedewald equation in most clinical environments: LDL-
C¼ (total cholesterol [TC]) – (high-density lipoprotein cho-
lesterol [HDL-C]) – (triglyceride [TG]/5).8 The final term,
which refers to the estimate of very low-density lipoprotein
cholesterol (VLDL-C), is calculated using a fixed denominator
of 5 in this equation. However, this uniformly fixed ratio has
been suspected to cause incorrect results because VLDL-C is a
group of various lipoproteins containing individually different
proportions of TG to TC.9
Many groups have consistently evaluated the accuracy of
the Friedewald equation in different ethnicities or various
disease entities, and proposed alternative formulas for more
precise LDL-C estimation until today. For instance, DeLong
et al proposed the expression (0.16TG) as a more accurate
estimate of VLDL-C, suggesting a fixed factor of 6 rather than
5.10 Other factor values have also been suggested in specificd factor appears to be accurate under all
high inter-individual variance in the
o date, none of proposed alternative
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methods have replaced the Friedewald equation in routine
clinical practice, and the National Cholesterol Education Pro-
gram (NCEP) still recommends the use of the original factor of
5 for estimating LDL-C.11
Recently, Martin et al have recommended a novel equation
to estimate LDL-C by applying an adjustable factor for the
TG:VLDL-C ratio, which was developed using a stratification
approach based on the levels of TG and non-HDL-C.9 This
formula was derived from the United States (US) population.
However, a subsequent validation study reported that this novel
equation has no clear benefit over the Friedewald calculation to
make changes in medical decisions.12
Although previous studies have already compared the
accuracy of several formulas to estimate LDL-C in relation
to the Friedewald equation, we compared a total of 10 formulas
for LDL-C calculation, including the latest novel method,9 to
the direct measurement of LDL-C. Therefore, the aim of this
study was to compare the 10 equations and validate the
most powerful method for LDL-C estimation, using the largest
cohort sample size to date. We validated the clinical utility
and application of different formulas for LDL-C calculation
not only in the hospitalized patients, but also in the
general population.
METHODS
Study Subjects
To compare the accuracy of LDL-C estimating equations,
we used two independent population datasets; the Severance
Hospital LDL-C (SHL) registry and the Korea National Health
and Nutrition Examination Survey (KNHANES) 2009–2010.
The SHL registry was established from the electronic
database of hospital patient records in Severance hospital for
this study. Severance hospital is a 2100-bed university-affiliated
teaching tertiary-level hospital in Seoul, Korea, with more than
10,000 outpatients visiting daily. From January 2008 to Decem-
ber 2013, we collected subjects who were aged 18 years and
whose lipid profiles (i.e., TC, HDL-C, LDL-C, and TG) were
directly measured from blood after overnight fasting. Among a
total of 164,358 subjects who were analyzed in the study, the
number of individuals with TG level higher than 400mg/dL was
1481, and this subgroup was independently reanalyzed for
hypertriglyceridemia in the ancillary study. The Institutional
Review Board of the Yonsei University College of Medicine
approved the present study project (No. 4-2015-0571).
To enhance the generalizability of validation, data from the
KNHANES 2009–2010 was independently analyzed. The
KNHANES is a nationwide cross-sectional study regularly
conducted by the Division of Chronic Disease Surveillance,
Korea Centers for Disease Control and Prevention of the
Ministry of Health and Welfare.13 A total of 19,491 individuals
participated in the KNHANES 2009–2010. Among these
participants, we excluded individuals who were aged<18 years
(n¼ 4659) and whose HDL-C or LDL-C was not assessed by
direct measurement in the survey (n¼ 10,870). Unlike the SHL,
subjects with TG higher than 400mg/dL (n¼ 108) were
excluded from the analysis to minimize biases by outliers
and to properly represent the general Korean population.
Finally, a total of 3854 subjects were investigated. Written
informed consent was secured from all participants and the
Rim et alKNHANES was conducted according to ethical approval by
Institutional Review Board of Korea Center for Disease Control
and Prevention (No: 2009-01CON-03-2C, 2010-02CON-21-C).
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In patients from the SHL, serum TC and TG levels were
determined by enzymatic method using reagents from Sekisui
Medical Corporation (Tokyo, Japan) and Roche Diagnostic
(Indianapolis, IN), respectively, on a Hitachi 7600 automated
chemistry analyzer (Hitachi, Tokyo, Japan). HDL-C and LDL-C
levels were measured by a homogenous direct assay using
reagents from Sekisui Medical Corporation on a Hitachi
7600 automated analyzer.
In the KNHANES 2009–2010, blood samples were col-
lected from each subject after overnight fasting for more than
8 hours, refrigerated immediately, transported in cold storage to
the central laboratory (Neodin Medical Institute, Seoul, Korea)
and analyzed within 24 hours after transportation.14 TC and TG
levels were determined by enzymatic method using reagents
from Sekisui Medical Corporation. HDL-C and LDL-C levels
were measured by a homogenous direct assay using reagents
from Sekisui Medical Corporation. All analytes were analyzed
on a Hitachi 7600 automated analyzer.
Equations for Estimating LDL-C
A total of 10 formulas for estimating LDL-C in units of
mg/dL are summarized in Supplementary Table 1, http://
links.lww.com/MD/A865. These include the novel 180-cell
(180-c) method9 along with equations suggested by Friedewald
et al,8 Hattori et al,15 Anandaraja et al,16 Chen et al,17 Cor-
dova,18 Teerakanchana et al,19 Ahmadi et al,20 DeLong et al,10
and Rao et al.21
Statistical Analyses
We assessed the agreement and accuracy of the 10
equations for estimating LDL-C using the direct LDL-C
measurement as the reference value. Two statistical concepts
were utilized for comparison of the accuracy of the 10 equations
compared to the direct LDL-C measurement.
Firstly, the intraclass correlation coefficient (ICC) was
calculated to compare the degrees of agreement between the
10 formulas and the direct LDL-C measurement. The level of
agreement was defined according to ICC value; good agreement
when ICC >0.75, and moderate agreement when 0.5< ICC
<0.75.22
Secondly, we calculated a weighted kappa (k) index to
compare the concordance for estimating LDL-C in relation to
the direct LDL-C measurement according to the LDL-C level
classification guideline. Similar to the ICCvalues, thek indexwas
used to define levels of agreement; good concordance when k
index >0.8, and substantial concordance when 0.6< k index
<0.8.23 To induce the k index from the datasets, two most
commonly used clinical practice guidelines to classify LDL-C
values were applied; the US guideline (<70, 70–99, 100–129,
130–159, 160–189, and 190mg/dL) and the European (EU)
guideline (<70, 70–99, 100–154, 155–189, and 190mg/
dL).6,7
Bland–Altman plots were also expressed to compare the
direct measurement of LDL-C and other estimates calculated
using the 10 equations.24 Categorical variables regarding con-
cordance were compared using the x2 test, whereas numerical
variables were compared using the t-test. A P <0.05 was
considered statistically significant. All statistical analyses were
performed using SAS version 9.2 (SAS Institute, Cary, NC),
Medicine  Volume 95, Number 14, April 2016MedCalc version 12.7 (MedCalc software, Ostend, Belgium), R
package version 3.0.2 (http://www.R-project.org), and SPSS
version 20.0 for Windows (IBM Corp., Armonk, NY).
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
RESULTS
Characteristics of Two Independent Population
Datasets—the SHL and the KNHANES 2009–
2010
Table 1 summarizes the general characteristics and lipid
profiles of subjects in two independent datasets; the SHL and
the KNHANES 2009–2010. Among a total of 164,358 subjects
in the SHL, 1,481 (0.9%) individuals showed TG level higher
than 400mg/dL. The mean age was older in the SHL than in the
KNHANES 2009–2010, possibly due to the difference between
the hospital registry and the general population.
Comparison of the Performance of the 10
Equations
The quantitative agreements according to ICC value
between the direct LDL-C measurement and other LDL-C
estimates using the 10 equations are presented in Table 2. Most
Medicine  Volume 95, Number 14, April 2016equations except the Ahmadi and Anandaraja formulas showed
ICCs >0.90 in both datasets, indicating excellent agreement
with the direct LDL-C measurement. ICCs of the 180-c (0.980),
TABLE 1. Characteristics of Study Subjects in the SHL and
KNHANES 2009–2010
SHL KNHANES 20092010
(N¼ 164,358) (N¼ 3,854)
Age (years) 55.7 15.3 45.0 15.3
Age group, N (%)
18–29 y 10,111 (6.2) 797 (20.7)
30–39 y 19,032 (11.6) 770 (20.0)
40–49 y 26,471 (16.1) 758 (19.7)
50–59 y 39,626 (24.1) 760 (19.7)
60–69 y 37,009 (22.5) 547 (14.2)
70 yþ 32,109 (19.5) 222 (5.8)
Sex, No (%)
Men 84,249 (51.3) 1871 (48.5)
Women 80,109 (48.7) 1983 (51.5)
Lipid profiles (mg/dL)
Total-C 177.9 39.2 186.1 35.7
HDL-C 49.2 13.1 48.5 10.9
LDL-C, direct 103.7 33.4 112.4 31.2
LDL-C, Friedewald 103.8 34.1 112.9 31.8
LDL-C, 180-c 106.1 33.1 114.8 31.1
Triglyceride 124.3 74.6 123.4 73.0
Triglyceride 400 1481 (0.9) –
Year
2008 20,482 (12.5)
2009 20,701 (12.6) 1929 (50.1)
2010 20,914 (12.7) 1925 (49.9)
2011 26,173 (15.9)
2012 31,160 (19.0)
2013 44,928 (27.3)
Data for continuous variables are expressed as mean standard
deviation.
CI¼ confidence interval, HDL-C¼ high-density lipoprotein choles-
terol, KNHANES¼Korea National Health and Nutrition Examination
Survey, LDL-C¼ low-density lipoprotein cholesterol, SD¼ standard
deviation, SHL¼Severance Hospital low-density lipoprotein choles-
terol registry, Total-C¼ total cholesterol.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.DeLong (0.980), and Chen (0.977) equations were superior to
that of the Friedewald equation (0.975) in the SHL. Similar
patterns were observed in the KNHANES 2009–2010. Mean
differences between direct LDL-C measurement and estimates
of each method were less than 10mg/dL in all equations except
the Ahmadi equation, indicating that most formulas investi-
gated in this study were comparable with the direct LDL-C
measurement in terms of ICC validation. The Bland–Altman
plots between LDL-C values determined by direct measurement
and other methods in the SHL are depicted in Supplementary
Figure 1, http://links.lww.com/MD/A865.
Concordance According to Clinical LDL-C
Classification Guidelines
The weighted k index was used to assess the concordance
between direct LDL-C measurement and other LDL-C esti-
mates calculated using equations according to the clinical
classification guidelines from the US and EU (Table 3). Only
two methods showed superior concordance with direct LDL-C
measurement when compared to the Friedewald equation; 180-c
and Chen equations [k index: 0.866 (0.865) and 0.863 (0.866)
according to US (EU) classification, respectively]. Other
equations showed inferior concordance when compared to
the Friedewald equation. Similar patterns were observed in
the KNHANES 2009–2010.
Comparison Between the Friedewald Equation
and the 180-c Method According to LDL-C Level
Since 180-c method showed the best agreement with direct
measurement among the 10 equations based on ICC and k
index, concordance of direct LDL-C measurement with LDL-C
estimates using the 180-c method was evaluated in comparison
with the Friedewald equation (Figure 1). Interestingly, the 180-c
method appeared to overestimate LDL-C values significantly
more often than the Friedewald equation (12.3% vs. 9.8%;
P< 0.001); however, the concordant percentage was also sig-
nificantly higher in the 180-c method (84.0% vs. 82.6%;
P< 0.001) (Figure 1A). After stratification by LDL-C level,
both Friedewald and 180-c equations tended to overestimate
LDL-C compared to direct measurement, especially in the low
ranges of LDL-C (<100mg/dL for Friedewald and< 130mg/
dL for 180-c), whereas both equations underestimated LDL-C
in the high ranges (Figure 1B and C).
Subgroup Analyses Based on LDL-C and TG
Levels Using the Friedewald Equation and the
180-cell Method
Subgroup analyses were performed to measure quantitat-
ive agreement using ICC values according to the strata of LDL-
C (<69, 70–99, 100–129, 130–159, and 160mg/dL) and TG
(<99, 100–149, 150–199, and 200–399mg/dL) levels. In other
words, direct LDL-C and TG levels were divided into 5 and 4
categories, respectively, to conduct a total of 20 comparisons in
different combinations. The quantitative agreement between
direct LDL-C measurement and the Friedewald or 180-cell
equation were compared by means of ICC values.
Overall, higher ICC values were observed in the 180-c
equation than the Friedewald equation for all subgroups
(Figure 2 and Supplementary Table 2, http://links.lww.com/
Validation of the 180-Cell Method in 168,212 AsiansMD/A865). However, the differences between the two
equations were not significant. Subjects with high LDL-C
(160mg/dL) and low TG (<150mg/dL) levels showed the
www.md-journal.com | 3
TABLE 2. Quantitative agreement by intraclass correlation coefficient between direct LDL-C and other equations for estimating
LDL-C
Intraclass
correlation coefficient
P-value
Mean Difference
Value 95% CI MeanSD 95% CI
SHL (N¼ 162,877)
LDL-C, Friedewald8 0.975 0.975–0.975 Reference 0.35 7.50 0.38–0.31
LDL-C, 180-c9 0.980 0.979–0.980 <0.00001 2.32 6.69 2.35–2.28
LDL-C, Hattori et al15 0.974 0.973–0.974 <0.00001 6.14 7.49 6.11–6.18
LDL-C, Anandaraja16 0.901 0.900–0.902 <0.00001 6.32 15.01 6.39–6.25
LDL-C, Chen et al17 0.977 0.977–0.977 <0.00001 0.42 6.95 0.39–0.46
LDL-C, Cordova and Cordova18 0.935 0.934–0.936 <0.00001 7.61 11.0 7.55–7.66
LDL-C, Teerakanchana et al19 0.973 0.973–0.973 <0.00001 6.39 7.57 6.43–6.36
LDL-C, Ahmadi et al20 0.584 0.581–0.587 <0.00001 26.05 40.27 26.24–25.85
LDL-C, DeLong10 0.980 0.980–0.980 <0.00001 5.17 6.76 5.20–5.14
LDL-C, Rao et al21 0.969 0.968–0.969 <0.00001 7.37 8.62 7.42–7.33
KNHANES (N¼ 3854)
LDL-C, Friedewald8 0.957 0.955–0.960 Reference 0.50 9.21 0.79–0.21
LDL-C, 180-c9 0.970 0.968–0.972 <0.00001 2.44 7.65 2.68–2.20
LDL-C, Hattori et al15 0.956 0.953–0.958 0.4554 6.52 9.09 6.23–6.80
LDL-C, Anandaraja et al16 0.867 0.859–0.875 <0.00001 4.89 15.88 5.39–4.39
LDL-C, Chen et al17 0.968 0.966–0.970 <0.00001 0.91 7.63 0.67–1.16
LDL-C, Cordova and Cordova18 0.927 0.923–0.932 <0.00001 9.21 11.07 8.86–9.55
LDL-C, Teerakanchana et al19 0.959 0.956–0.962 0.1253 5.74 8.71 6.02–5.47
LDL-C, Ahmadi et al20 0.509 0.485–0.532 <0.00001 26.82 46.55 28.29–25.35
LDL-C, DeLong et al10 0.968 0.965–0.970 <0.00001 5.44 8.06 5.69–5.18
LDL-C, Rao et al21 0.947 0.943–0.950 <0.00001 7.84 10.53 8.18–7.51
Subjects with triglyceride 400mg/dl were excluded from the analysis.
Mean Difference¼ [LDL-C measured by the direct method] – [LDL-C estimated by specific methods indicated above].
CI¼ confidence interval, KNHANES¼Korea National Health and Nutrition Examination Survey, LDL-C¼ low-density lipoprotein cholesterol,
otei
Rim et al Medicine  Volume 95, Number 14, April 2016best agreement by the 180-c equation (ICC: 0.93), and the
Friedewald equation (ICC: 0.92). Subjects with the lowest
LDL-C (<70mg/dL) and TG (<100mg/dL) levels also showed
comparable ICCs as determined by both equations (ICC by 180-
c: 0.92, ICC by Friedewald: 0.91). Regardless of TG level, ICCs
by the Friedewald or 180-c equation were >0.90 in subjects
with the highest LDL-C (160mg/dL), indicating very strong
agreement with direct LDL-C measurement in this subpopu-
lation. However, in subjects with LDL-C <160mg/dL, the ICC
decreased significantly with increasing TG concentration,
resulting in the worst agreement with direct LDL-C measure-
ment in individuals with TG 200mg/dL (all ICCs <0.65).
Ancillary Analyses for the Hypertriglyceridemic
Subpopulation
Quantitative and qualitative agreements between direct
LDL-C measurement and other LDL-C estimates calculated
using the different equations were assessed in subjects with TG
level 400mg/dL derived from the SHL. Among the 10
formulas, the 180-c equation showed the best agreement with
direct LDL-Cmeasurement (ICC: 0.82, P< 0.001), followed by
Teerakanchana’s equation (ICC: 0.81, P< 0.001) (Supple-
SD¼ standard deviation, SHL¼Severance Hospital low-density lipoprmentary Table 3, http://links.lww.com/MD/A865). The
equations proposed by Chen, Anandaraja, and DeLong also
showed better agreement with direct LDL-C measurement than
4 | www.md-journal.comdid the Friedewald equation (ICC: 0.77). Supplementary Table
4, http://links.lww.com/MD/A865 describes the concordance
levels between direct LDL-C measurement and other LDL-C
estimates in terms of weighted k index in subjects with TG level
400mg/dL, using the same classification as in previous
analyses. The DeLong equation showed the best concordance
with direct LDL-C measurement [k index: 0.618 (0.617) by US
(EU) classification], superior to that of the Friedewald equation.
The 180-c equation resulted in inferior concordance compared
to the Friedewald equation.
DISCUSSION
The international guidelines for CVD treatment continu-
ously emphasize the importance of LDL-C assay for risk
assessment and patient follow-up.4–7,25 The current NCEP
Adult Treatment Panel recommendations for cardiovascular
risk assessment are mostly based on early epidemiologic studies
that used the Friedewald equation to estimate LDL-C.4 How-
ever, the accuracy of the Friedewald formula has been called
into question based on several critical limitations including
inaccuracy in patients with hypertriglyceridemia, subjects with
very low TG level, and patients with liver or renal disease.
n cholesterol registry.Although the Friedewald equation has been traditionally
believed to show high accuracy compared to b-quantification
when TG <4.52mmol/L (or 400mg/dL), this has been also
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 3. Weighted Kappa Index: Concordance in Guideline Classification of LDL-C Levels by Friedewald versus Other Equations
for Estimating LDL-C in Relation to Direct LDL-C
US Guideline EU Guideline
Weighted Kappa SE P-value Weighted Kappa SE P-value
SHL (N¼ 162,877)
LDL-C, Friedewald et al8 0.856 0.0008 – 0.854 0.0009 –
LDL-C, 180-c9 0.866 0.0008 <0.00001 0.865 0.0009 <0.00001
LDL-C, Hattori et al15 0.806 0.0009 <0.00001 0.812 0.001 <0.00001
LDL-C, Anandaraja et al16 0.678 0.0012 <0.00001 0.673 0.0014 <0.00001
LDL-C, Chen et al17 0.863 0.0008 <0.00001 0.866 0.0009 <0.00001
LDL-C, Cordova and Cordova18 0.695 0.0011 <0.00001 0.724 0.0012 <0.00001
LDL-C, Teerakanchana et al19 0.789 0.001 <0.00001 0.776 0.0012 <0.00001
LDL-C, Ahmadi et al20 0.395 0.0013 <0.00001 0.394 0.0015 <0.00001
LDL-C, DeLong et al10 0.825 0.0009 <0.00001 0.823 0.001 <0.00001
LDL-C, Rao et al21 0.759 0.001 <0.00001 0.757 0.0012 <0.00001
KNHANES (N¼ 3854)
LDL-C, Friedewald et al8 0.804 0.0062 – 0.788 0.0078 –
LDL-C, 180-c9 0.835 0.0058 0.0003 0.822 0.0073 0.0015
LDL-C, Hattori et al15 0.762 0.0068 <0.00001 0.757 0.0081 0.0058
LDL-C, Anandaraja et al16 0.631 0.0084 <0.00001 0.603 0.0103 <0.00001
LDL-C, Chen et al17 0.837 0.0058 0.0001 0.831 0.0071 <0.00001
LDL-C, Cordova and Cordova18 0.65 0.0077 <0.00001 0.666 0.0092 <0.00001
LDL-C, Teerakanchana et al19 0.761 0.0067 <0.00001 0.731 0.0086 <0.00001
LDL-C, Ahmadi et al20 0.381 0.0086 <0.00001 0.366 0.0094 <0.00001
LDL-C, DeLong et al10 0.787 0.0063 0.0544 0.768 0.008 0.0734
LDL-C, Rao et al21 0.703 0.007 <0.00001 0.68 0.0089 <0.00001
Subjects with triglyceride 400mg/dL were excluded from the analysis.
KNHANES¼Korea National Health and Nutrition Examination Survey, LDL-C¼ low-density lipoprotein cholesterol, SE¼ standard error,
SHL¼Severance Hospital low-density lipoprotein cholesterol registry.
Medicine  Volume 95, Number 14, April 2016 Validation of the 180-Cell Method in 168,212 Asianssuspected with the development of new direct LDL-C assays.26
These shortcomings of the Friedewald formula have prompted
the recent development of new equations for LDL-C calcu-
lation. Among the formulas developed to overcome problems of
the Friedewald equation, the most up-to-date 180-cell method
derived from a US population has been highlighted for possib-
ility to be used in practice with high accuracy, which applies an
adjustable factor for the TG:VLDL-C ratio using a stratification
approach according to TG and non-HDL-C levels.9 This esti-
mation method was shown to provide higher fidelity estimates
than the Friedewald equation, resulting in more accurate guide-
line risk classification.9 However, these favorable findings are
required to be externally validated in different ethnicities before
being applied to other populations. Although one study12
validating the novel 180-cell method concluded that its
improvement over the Friedewald equation is not sufficient
to supplant the original formula, the results in this study were
derived from another US population. To the best of our know-
ledge, this is the first study to validate a new stratification
approach in an Asian population using two independent large
populations: one hospital patient based cohort and one
general population.
Among the 10 equations compared in the present study, all
equations except the Ahmadi equation revealed ICC >0.90,
suggesting that these equations are in good accordance with
direct LDL-C measurement. The fact that the Ahmadi equation
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.was derived only from the patients with high cholesterol
(>250mg/dL) could have caused this inferior ICC value com-
pared to those of other formulas. When we analyzed k index to
distinguish the most concordant equation, two most accurate
methods showing the best concordance agreement according
to NCEP category with direct LDL-C measurement were the
180-c method and the Chen equation [k index: 0.866 (0.865)
and 0.863 (0.866) by US (EU) classification, respectively].
The Friedewald and DeLong equations followed with k index
of 0.856 (0.854) and 0.825 (0.823) by US (EU) classification,
respectively.
Considering the results of several previous reports by
objective third parties who focused on the validation and
comparison of suggested equations for LDL-C estimation,
our results highlight the superior performance of the novel
180-c method. Also our data support the good predictive
performance of the Chen equation, which has been undervalued
in other reports. Martins et al recently reported that the Hattori
formula performed the best in hospitalized patients when
compared to the Friedewald, Chen and Cordova equations.27
Although direct LDL-C measurement was used for reference
value in comparisons (as in our study), the use of different
reagents and instruments for lipid measurements as well as
different ethnicities and populations with various health con-
ditions might have caused the discordant findings with our
results. On the contrary, Oliveira et al concluded that the
www.md-journal.com | 5
FIGURE 1. Concordance of direct LDL-C with LDL-C using the Friedewald or 180-cell equations (A), and concordance according to LDL-C
stratum between direct LDL-C and Friedewald (B) or 180-cell equations (C). LDL-C¼ low-density lipoprotein cholesterol.
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FIGURE 2. Quantitative agreement by intraclass correlation
coefficient between direct LDL-C and other equations for estimat-
ing LDL-C by different strata of LDL-C and triglycerides in the
Medicine  Volume 95, Number 14, April 2016Friedewald equation showed the best accuracy when compared
to the Chen, Anandaraja, and Vujovic (which was not included
in this study) formulas.28 Even though the reference method was
different from that in our study (b-quantification in Oliveira’s
study), none of the equations performed adequately for hyper-
triglyceridemic patients, which is in line with our findings.
When we focused on the comparison of only the 180-c
method and the Friedewald equation, the ICC of the 180-c
method (0.980) was superior to that of the Friedewald equation
(0.975) in the SHL. In all subgroups classified by different strata
of TG and LDL-C levels, higher ICC values were also observed
using the 180-c method compared to the Friedewald equation;
however, the difference between the ICC values was small.
These results suggest that the novel 180-c method can be
suitably and appropriately applied in Asian populations.
Furthermore, it might perform more accurately than the Frie-
dewald equation in all ranges of TG and LDL-C.
One interesting result in this study was that the ICC values
for subgroup with LDL-C>160mg/dL consistently showed the
highest values with only a slight decreasing trend as TG level
increased. However, in the subgroup with LDL-C<160mg/dL,
the ICC values proportionally decreased by significant amounts
as TG level increased, resulting in ICC values of 0.54 to 0.63
among the subgroup with TG level of 200 to 399mg/dL. From
the clinical perspective, this finding is important because
physicians can easily use and rely on the Friedewald or 180-
c equation at their discretion in order to manage patients with
high level of LDL-C (>160mg/dL). Relatively small differ-
ences between direct LDL-C measurement and LDL-C esti-
mates calculated using the other equations might not crucially
change the treatment practice among patients who are already
being treated. More importantly, a relatively large bias of LDL-
C estimate in individuals with a low or middle range LDL-C is
of serious concern because this underestimation will delay
timely prevention and appropriate treatment for dyslipidemia.
This is especially true for Asian populations because large
proportion of the population was reported to be unaware of
high LDL-C.29
From the results of subpopulation analyses, we challenged
SHL cohort (F, Friedewald equation;8 180-c, 180-cell equation).9
LDL-C¼ low-density lipoprotein cholesterol, SHL¼ Severance
Hospital LDL-C.to find out the best equation to estimate LDL-C level in patients
with hypertriglyceridemia, which is the most commonly recog-
nized factor to cause misleading estimated as determined by the
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.Friedewald equation.Among the 7 equations that hada good level
of agreement according to the ICC value, the 180-c method
outperformed all other equations in estimating LDL-C compared
to direct measurement. Meanwhile, the Friedewald equation was
indeed inferior to 6 equations in hypertriglyceridemic conditions.
Whenwecompared theperformances of the10 equations in terms
of k index, all equations except the DeLong formula showed poor
concordance level, not satisfying theminimumvalueof 0.6. Since
the DeLong equation was the only formula that demonstrated
fairly good agreement and concordance level by the indices of
ICC and k index, we propose that physicians consider using the
DeLong equation for LDL-C prediction in patients with hyper-
triglyceridemia. However, it is important to realize that the
performance of all the suggested equations in the hypertriglyceri-
demic subpopulation was worse than that of the subgroup with
TG level <400mg/dL. Therefore, we suggest that the critical
limitation of the LDL-C formulas still remains in patients with
hypertriglyceridemia despite the development of several new
equations.
One limitation in this study is that we used direct hom-
ogenousLDL-Cmeasurement as the reference value instead ofb-
quantification. Due to the limited clinical availability of b-
quantification, direct LDL-C assays have frequently served as
the reference values in several reports validating different
equations for LDL-C estimation. To avoid incorrect comparisons
of formulas with direct LDL-C data obtained from different
methods, we used only one direct LDL-C assay (Sekisui reagent),
whichwas reported to perform the best among seven assays when
compared tob-quantification.30Another limitation of our study is
the different TC and TG assays used in two independent popu-
lations. However, a recent study reported that the use of different
directHDLassays ismore likely to significantly affect theLDL-C
estimates than various TC and TG methods because of the better
standardization of TC and TG.31
In conclusion, we compared the novel 180-c method for
LDL-C estimation with 9 previously reported formulas in a
Korean population as the first external validation in a non-US
population. The 180-c equation appeared to be more accurate
than the most commonly used Friedewald equation, along with
the Chen equation. Although the DeLong equation showed
better performance in the hypertriglyceridemic subpopulation,
Validation of the 180-Cell Method in 168,212 Asiansthe 180-c method might perform better in hospitalized
Korean patients as well as a general Korean population
without hypertriglyceridemia.
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